Skip to content

Drug interactions

Lonafarnib + Palbociclib

Severity: Moderate

Lonafarnib and Palbociclib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Palbociclib may weakly inhibit CYP3A4 and raise levels of lonafarnib, a sensitive CYP3A substrate. Higher lonafarnib exposure may increase its adverse effects, including gastrointestinal toxicity and possible QT effects.

What this interaction means in plain words

Lonafarnib and Palbociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lonafarnib belongs to Miscellaneous; Palbociclib belongs to Oncology.

Evidence level: Low

Why it happens

Palbociclib inhibits CYP3A4, reducing lonafarnib metabolism.

What to do

Monitor for lonafarnib toxicity and cardiac symptoms, and consider ECG monitoring. Keep lonafarnib at the lowest recommended dose.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lonafarnib and Palbociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lonafarnib with Palbociclib?

MediHelp rates the interaction as moderate. Lonafarnib and Palbociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Palbociclib may weakly inhibit CYP3A4 and raise levels of lonafarnib, a sensitive CYP3A substrate. Higher lonafarnib exposure may increase its adverse effects, including gastrointestinal toxicity and possible QT effects.

How serious is the interaction between Lonafarnib and Palbociclib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for lonafarnib toxicity and cardiac symptoms, and consider ECG monitoring. Keep lonafarnib at the lowest recommended dose.

What other medicines interact with Palbociclib?

MediHelp also lists interactions of Palbociclib with, for example, Apalutamide, Atazanavir, Carbamazepine. The full list is on the Palbociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in